Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial
Abstract Introduction Cholangiocarcinoma (CCA) is an aggressive cancer characterized by high metastatic potential and poor prognosis. Recent advances in understanding the molecular biology of CCA have led to the development of novel therapeutic strategies. However, the immunosuppressive tumor microe...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Epigenetics Communications |
| Online Access: | https://doi.org/10.1186/s43682-025-00037-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|